about
A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfationMicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting Mdm2Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilageOn the evolutionary relationship between chondrocytes and osteoblastsEpigenetic Regulation of Chondrocyte Catabolism and Anabolism in OsteoarthritisFactors influencing the long-term behavior of extracellular matrix-derived scaffolds for musculoskeletal soft tissue repairOsteoarthritis pathogenesis: a review of molecular mechanismsEngineered cartilaginous tubes for tracheal tissue replacement via self-assembly and fusion of human mesenchymal stem cell constructsApplications of Chondrocyte-Based Cartilage Engineering: An OverviewIdentification and analysis of the promoter region of the human hyaluronan synthase 2 genePhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsDistribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cordKnockdown of the intraflagellar transport protein IFT46 stimulates selective gene expression in mouse chondrocytes and affects early development in zebrafishNondestructive Techniques to Evaluate the Characteristics and Development of Engineered Cartilage.Organization and adhesive properties of the hyaluronan pericellular coat of chondrocytes and epithelial cells.Chondroitin-4-sulfation negatively regulates axonal guidance and growthFibronectin matrix assembly is essential for cell condensation during chondrogenesis.Identification and initial characterization of 6,000 expressed sequenced tags (ESTs) from rat normal-growing cartilage and swarm rat chondrosarcoma cDNA libraries.CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention.Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.Development and retranslational validation of an in vitro model to characterize acute infections in large human joints.Extracellular matrix molecules: potential targets in pharmacotherapy.Effects of moniliformin and selenium on human articular cartilage metabolism and their potential relationships to the pathogenesis of Kashin-Beck disease.Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chickSec24D-dependent transport of extracellular matrix proteins is required for zebrafish skeletal morphogenesis.Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.UDP xylose synthase 1 is required for morphogenesis and histogenesis of the craniofacial skeleton.Hyaluronic acid as an internal wetting agent in model DMAA/TRIS contact lenses.Defining the earliest transcriptional steps of chondrogenic progenitor specification during the formation of the digits in the embryonic limb.Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy.Knockdown of zebrafish lumican gene (zlum) causes scleral thinning and increased size of scleral coats.Mechanisms balancing skeletal matrix synthesis and degradation.Soluble lumican glycoprotein purified from human amniotic membrane promotes corneal epithelial wound healingThe effects of hyaluronic acid incorporated as a wetting agent on lysozyme denaturation in model contact lens materials.Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses.Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.Fibronectin and stem cell differentiation - lessons from chondrogenesis.
P2860
Q24322895-8881CEA5-885E-4360-B26F-66079B6B5766Q24621351-F81EA50C-0D44-42A0-8BC0-0126BDEBBCFBQ24654744-FF65D9A2-F8BA-4F08-8E0C-CCDEDFEC8D57Q26781138-D387531C-DBEC-47F0-A357-3DF74B98542CQ26799110-B1370D3A-002B-46A3-AE19-FFBBF5C513C2Q26821999-D6BD2A88-D98F-4AAF-87C9-027530439FA5Q26865318-68D9D19A-03E0-4F8B-B5B2-AD228B51D9D2Q27329993-44E72379-6F97-4B9E-8F12-E9EFFE97A028Q28077670-5BFF6B49-035C-42E6-B9B1-5B76DCB8EBFAQ28247226-C765BA06-5001-41FE-97A9-D574CCFB8FDCQ28286551-54C89BA0-415C-4272-BCCC-CEF819DA9D2DQ28571518-EAFDC036-2373-4A89-9BB6-24A71CE7D507Q28592778-4B3C44A8-26FC-4388-AB95-4BEB22481B5DQ30362050-43F76E1B-A391-4AD0-9BEC-8E8D1C59CDF8Q30476431-18D688C0-486E-4899-9BB2-27CD3987E94AQ30483928-F1014798-45D0-4437-8A0C-2D1D886F3B62Q30592327-D76C9544-C69D-4F36-AE81-FB6ED5881449Q31104086-C15BBF42-68F3-44FE-9103-B5594DEED6A4Q32872051-ECB7E61F-C910-4030-BBD6-86A208E266C8Q33303263-BECDB2D0-CB3C-4B58-9447-C1F5861F99D3Q33325058-5B94FF6C-EC53-43C7-8592-792697609968Q33615549-0BEF8D46-E304-4DC6-BA92-036808946EDDQ33694487-E5FC16E1-33EC-426A-9C97-0C201892B236Q33708669-53666888-A462-41B8-8F62-9EA34F041869Q33732324-01F39F01-8372-429B-9D73-3AAAEBFDBD54Q33742165-FFB530D8-108B-46E5-9FE5-BF484FC42B5AQ33815925-94C64EB8-D10B-4F3D-B8CC-1DC4D4D56D1CQ33854827-F62EE0B0-6B2F-4FEE-AA1F-6287A3BAA339Q33922775-5670808D-F0C4-40CC-9523-CEE2363C87CFQ33959003-6637EFE6-BF1E-429B-899C-A1333E2C5616Q34023633-221E873A-EA48-4E2B-A610-45B26DD17C94Q34099564-6F683402-E120-416E-8F89-C4E20DB113CEQ34107412-B951920A-EFAA-42D8-A3D7-9EBD93B68D0CQ34129759-EA2E3F4A-9F10-4961-8AC4-DABE639A1691Q34232114-45E57B84-D5E1-4B7F-9FBF-24EDD630117AQ34259156-BF2A3215-B15B-459A-968B-46058FDA18E6Q34261263-8F9D11CE-57A9-47A4-B9CA-54C0AE268432Q34285507-7F54B775-A2A1-467E-8ECF-BC8E16D3901AQ34631606-BD851AD4-4B8A-44FB-9D72-D6DB9DEFD036Q34642639-76C4B2B5-40FB-474D-A682-B484D36D2FB6
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cartilage proteoglycans.
@ast
Cartilage proteoglycans.
@en
Cartilage proteoglycans.
@nl
type
label
Cartilage proteoglycans.
@ast
Cartilage proteoglycans.
@en
Cartilage proteoglycans.
@nl
prefLabel
Cartilage proteoglycans.
@ast
Cartilage proteoglycans.
@en
Cartilage proteoglycans.
@nl
P356
P1476
Cartilage proteoglycans.
@en
P2093
C B Knudson
P356
10.1006/SCDB.2000.0243
P577
2001-04-01T00:00:00Z